Keamanan dan Efikasi Sputnik V, Vaksin COVID-19 Heterolog Berbasis Vektor rAd26 dan rAd5: Analisis Interim Uji Acak Terkontrol Fase 3 di Rusia - Telaah Jurnal Alomedika

Oleh :
dr.Eduward Thendiono, SpPD,FINASIM

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2. Erratum in: Lancet. 2021 Feb 20;397(10275):670.

Abstrak

Referensi